Plant ID: NPO6190
Plant Latin Name: Angelica archangelica
Taxonomy Genus: Angelica
Taxonomy Family: Apiaceae
NCBI TaxonomyDB:
40949
Plant-of-the-World-Online:
837560-1
Antispasmodic; Appetizer; Carminative; Diaphoretic; Diuretic; Expectorant; Stimulant; Stomachic; Tonic
Ukraine; Netherlands; Belarus; Lithuania; Denmark; Finland; India; Romania; France; United Kingdom; Sweden; Albania; China; Iceland; Belgium; Germany; Russia; Greenland; Bulgaria
ATP12A; GAA; | |
MAPK1; | |
CA13; CA1; CA7; CA12; CA9; | |
ALDH1A1; POLB; | |
MAPT; PAX8; NPC1; XPO1; RAB9A; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2A13 | Cytochrome P450 2A13 | Q16696 | CHEMBL3542436 |
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Hydrolase | ATP12A | Potassium-transporting ATPase alpha chain 2 | P54707 | CHEMBL2933 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Lyase | CA13 | Carbonic anhydrase XIII | Q8N1Q1 | CHEMBL3912 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | PAX8 | Paired box protein Pax-8 | Q06710 | CHEMBL2362980 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
Unclassified | XPO1 | Exportin-1 | O14980 | CHEMBL5661 |
Unclassified | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 2.065E-12 | 4.497E-08 | CA1, CA12, CA13, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.558E-10 | 1.392E-06 | CA1, CA12, CA13, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 7.330E-10 | 3.192E-06 | CA1, CA12, CA13, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 4.945E-09 | 1.346E-05 | CYP1A2, CYP2A13, CYP2A6, CYP2C19 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.895E-08 | 4.126E-05 | CYP1A2, CYP2C19, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0009804; coumarin metabolic process | 3.314E-08 | 5.154E-05 | CYP2A13, CYP2A6, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 3.799E-08 | 5.170E-05 | CYP2A13, CYP2A6, CYP2C19, CYP2D6 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.212E-07 | 1.319E-04 | CYP1A2, CYP2A13, CYP2C19, CYP2D6 |
MF | GO:0005488; binding | GO:0020037; heme binding | 1.691E-07 | 1.753E-04 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2D6 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 2.076E-07 | 1.965E-04 | CYP1A2, CYP2A6, CYP2C19 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 5.136E-07 | 4.142E-04 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0008392; arachidonic acid epoxygenase activity | 6.395E-07 | 4.802E-04 | CYP2A13, CYP2A6, CYP2C19 |
MF | GO:0003824; catalytic activity | GO:0008389; coumarin 7-hydroxylase activity | 1.019E-06 | 7.393E-04 | CYP2A13, CYP2A6 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 1.659E-06 | 1.165E-03 | CYP1A2, CYP2A13, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 4.351E-06 | 2.871E-03 | CYP1A2, CYP2A6, CYP2C19, CYP2D6, NPC1 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 5.183E-06 | 3.225E-03 | CYP1A2, CYP2A13, CYP2C19, CYP2D6 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 3.573E-12 | 3.930E-10 | CA12, CA1, CA7, CA9, CA13 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 6.028E-07 | 2.776E-05 | CYP2A6, CYP2D6, CYP1A2, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 7.570E-07 | 2.776E-05 | CYP2A6, CYP2A13, CYP2D6, CYP1A2 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.210E-06 | 3.326E-05 | CYP2A6, CYP2A13, CYP1A2, CYP2C19 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 3.590E-05 | 6.582E-04 | CYP2A6, CYP1A2, ALDH1A1 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.818E-04 | 2.857E-03 | CYP2D6, MAPK1, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 3.795E-04 | 4.639E-03 | PAX8, MAPK1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 3.795E-04 | 4.639E-03 | CYP1A2, CYP2C19 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 6.417E-03 | 6.630E-02 | CYP2A6, GAA, CYP1A2, ALDH1A1, CYP2C19 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 9.483E-06 | 2.086E-04 | CYP2A6, CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Breast cancer | C50 | CA9; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |
E00-E89: Endocrine, nutritional and metabolic diseases | Pompe's disease | E74.02 | GAA; |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; |